Osmolar gap
The Osmolality page has been updated with additional information about causes of an increased osmolar gap.
Dunn RJ
The Osmolality page has been updated with additional information about causes of an increased osmolar gap.
The Methanol page will be updated to indicate that although methanol is not supposed to be present in methylated spirits in Australia, at least one brand was found to contain 66% methanol in Feb 2020 – so beware!
The Opioid antagonists & partial agonists page has been updated with some additional information about naloxone nasal spray
The Other sedatives page has been updated with additional information about baclofen toxicity and intrathecal pumps.
A segment about the therapeutic effects of cannabinoids has been added to the Other drugs of abuse page.
Some information about cannabidiol has been added to the Other drugs of abuse page.
A 10 question quiz about paracetamol poisoning has been added to the Other quizzes page based on the recently released Australian and New Zealand guidelines. Chiew, AL, Reith, D, Pomerleau, A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust 2019. The 10 questions are randomly … Read more
The Paracetamol page has been updated with information from the new paracetamol management guidelines for Australia and New Zealand,
The Smoking page has been updated with some additional information about the effects of vaping.
The Lead page has been updated with a variety of additional details.
The Smoking page has been updated with a revised segment on E cigarettes, including the risk of lung injury.
The Opioid antagonists & partial antagonists page has been updated, including information about a 5 day suboxone withdrawal treatment regimen.
The Other toxic alcohols page has been updated with some additional information about isopropyl alcohol.
The Stimulants page has been updated with a variety of additions to the segment on amphetamines – the modern scourge of the ED.
The Anti-psychotic agents page has been updated, including significant revision of the segment on quetiapine.
The Paracetamol page has been extensively revised and updated, including simplification and removal of some redundant content.
The Warfarin page has been updated with additional information about the need for close monitoring following superwarfarin ingestion and the need for ongoing, tapering vitamin K therapy.
The Other drugs of abuse page has been updated with the addition of coagulopathy as a potential adverse effect of synthetic cannabinoid ingestion due to mixture with long acting Vitamin K antagonists.
The Organophosphates page has had a number of minor updates.
The Methanol page has been updated with some minor modifications.